APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor IV

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Coagulation Factor IV Industry Growth and Trends Forecast to 2032

Report ID 173999550122 December 2025104 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor IV Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor IV Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor IV Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor IV Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor IV Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Human Coagulation Factor IV market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Coagulation Factor IV is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Coagulation Factor IV is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Coagulation Factor IV is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Coagulation Factor IV include BPL, CSL, Greencross, Grifols, Kedrion, Octapharma, Baxter, Bayer and Biogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Coagulation Factor IV market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Coagulation Factor IV market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Coagulation Factor IV market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Coagulation Factor IV.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Coagulation Factor IV market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Coagulation Factor IV Market by Company

BPL

CSL

Greencross

Grifols

Kedrion

Octapharma

Baxter

Bayer

Biogen

Hualan Bio

Pfizer

RAAS

Novo Nordisk

Human Coagulation Factor IV Segment by Type

Calcium Ion

Calcium Compounds

Human Coagulation Factor IV Segment by Application

Hospital

Personal Clinic

Others

Human Coagulation Factor IV Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor IV market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor IV and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor IV.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Coagulation Factor IV manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Coagulation Factor IV in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Calcium Ion Table 2. Major Company of Calcium Compounds Table 3. Global Human Coagulation Factor IV Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Coagulation Factor IV Sales by Type (2021-2026) & (k units) Table 5. Global Human Coagulation Factor IV Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Coagulation Factor IV Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Coagulation Factor IV Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Coagulation Factor IV Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Coagulation Factor IV Sales by Type (2027-2032) & (k units) Table 10. Global Human Coagulation Factor IV Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Coagulation Factor IV Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Coagulation Factor IV Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Coagulation Factor IV Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Coagulation Factor IV Sales by Type (2021-2026) & (k units) Table 15. North America Human Coagulation Factor IV Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Coagulation Factor IV Sales by Type (2021-2026) & (k units) Table 17. Europe Human Coagulation Factor IV Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Coagulation Factor IV Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Human Coagulation Factor IV Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Coagulation Factor IV Sales by Type (2021-2026) & (k units) Table 21. Latin America Human Coagulation Factor IV Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Coagulation Factor IV Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Human Coagulation Factor IV Sales by Type (2021-2026) & (US$ Million) Table 24. Human Coagulation Factor IV Industry Trends Table 25. Human Coagulation Factor IV Industry Drivers Table 26. Human Coagulation Factor IV Industry Opportunities and Challenges Table 27. Human Coagulation Factor IV Industry Restraints Table 28. Global Human Coagulation Factor IV Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Coagulation Factor IV Revenue Market Share by Company (2021-2026) Table 30. Global Human Coagulation Factor IV Sales by Company (2021-2026) & (k units) Table 31. Global Human Coagulation Factor IV Sales Share by Company (2021-2026) Table 32. Global Human Coagulation Factor IV Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Coagulation Factor IV Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Coagulation Factor IV Major Company Production Sites and Headquarters Table 35. Global Human Coagulation Factor IV Company, Product Type & Application Table 36. Global Human Coagulation Factor IV Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Coagulation Factor IV by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Coagulation Factor IV Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Coagulation Factor IV Sales by Region (2021-2026) & (k units) Table 41. Global Human Coagulation Factor IV Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Coagulation Factor IV Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Coagulation Factor IV Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Coagulation Factor IV Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Coagulation Factor IV Sales by Region (2027-2032) & (k units) Table 46. Global Human Coagulation Factor IV Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Coagulation Factor IV Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Coagulation Factor IV Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Coagulation Factor IV Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Coagulation Factor IV Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Coagulation Factor IV Sales by Application (2021-2026) & (k units) Table 52. Global Human Coagulation Factor IV Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Coagulation Factor IV Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Coagulation Factor IV Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Coagulation Factor IV Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Coagulation Factor IV Sales by Application (2027-2032) & (k units) Table 57. Global Human Coagulation Factor IV Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Coagulation Factor IV Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Coagulation Factor IV Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Coagulation Factor IV Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Coagulation Factor IV Sales by Application (2021-2026) & (k units) Table 62. North America Human Coagulation Factor IV Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Coagulation Factor IV Sales by Application (2021-2026) & (k units) Table 64. Europe Human Coagulation Factor IV Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Coagulation Factor IV Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Human Coagulation Factor IV Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Coagulation Factor IV Sales by Application (2021-2026) & (k units) Table 68. Latin America Human Coagulation Factor IV Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Coagulation Factor IV Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Human Coagulation Factor IV Sales by Application (2021-2026) & (US$ Million) Table 71. BPL Company Information Table 72. BPL Business Overview Table 73. BPL Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. BPL Human Coagulation Factor IV Product Portfolio Table 75. BPL Recent Development Table 76. CSL Company Information Table 77. CSL Business Overview Table 78. CSL Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CSL Human Coagulation Factor IV Product Portfolio Table 80. CSL Recent Development Table 81. Greencross Company Information Table 82. Greencross Business Overview Table 83. Greencross Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Greencross Human Coagulation Factor IV Product Portfolio Table 85. Greencross Recent Development Table 86. Grifols Company Information Table 87. Grifols Business Overview Table 88. Grifols Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Grifols Human Coagulation Factor IV Product Portfolio Table 90. Grifols Recent Development Table 91. Kedrion Company Information Table 92. Kedrion Business Overview Table 93. Kedrion Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Kedrion Human Coagulation Factor IV Product Portfolio Table 95. Kedrion Recent Development Table 96. Octapharma Company Information Table 97. Octapharma Business Overview Table 98. Octapharma Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Octapharma Human Coagulation Factor IV Product Portfolio Table 100. Octapharma Recent Development Table 101. Baxter Company Information Table 102. Baxter Business Overview Table 103. Baxter Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Baxter Human Coagulation Factor IV Product Portfolio Table 105. Baxter Recent Development Table 106. Bayer Company Information Table 107. Bayer Business Overview Table 108. Bayer Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Bayer Human Coagulation Factor IV Product Portfolio Table 110. Bayer Recent Development Table 111. Biogen Company Information Table 112. Biogen Business Overview Table 113. Biogen Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Biogen Human Coagulation Factor IV Product Portfolio Table 115. Biogen Recent Development Table 116. Hualan Bio Company Information Table 117. Hualan Bio Business Overview Table 118. Hualan Bio Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Hualan Bio Human Coagulation Factor IV Product Portfolio Table 120. Hualan Bio Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Pfizer Human Coagulation Factor IV Product Portfolio Table 125. Pfizer Recent Development Table 126. RAAS Company Information Table 127. RAAS Business Overview Table 128. RAAS Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. RAAS Human Coagulation Factor IV Product Portfolio Table 130. RAAS Recent Development Table 131. Novo Nordisk Company Information Table 132. Novo Nordisk Business Overview Table 133. Novo Nordisk Human Coagulation Factor IV Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Novo Nordisk Human Coagulation Factor IV Product Portfolio Table 135. Novo Nordisk Recent Development Table 136. North America Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Human Coagulation Factor IV Sales by Country (2021-2026) & (k units) Table 138. North America Human Coagulation Factor IV Sales Market Share by Country (2021-2026) Table 139. North America Human Coagulation Factor IV Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Human Coagulation Factor IV Sales Market Share Forecast by Country (2027-2032) Table 141. North America Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Human Coagulation Factor IV Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Human Coagulation Factor IV Market Share by Country (2021-2026) Table 144. North America Human Coagulation Factor IV Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Human Coagulation Factor IV Market Share Forecast by Country (2027-2032) Table 146. Europe Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Human Coagulation Factor IV Sales by Country (2021-2026) & (k units) Table 148. Europe Human Coagulation Factor IV Sales Market Share by Country (2021-2026) Table 149. Europe Human Coagulation Factor IV Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Human Coagulation Factor IV Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Human Coagulation Factor IV Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Human Coagulation Factor IV Market Share by Country (2021-2026) Table 154. Europe Human Coagulation Factor IV Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Human Coagulation Factor IV Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Human Coagulation Factor IV Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Human Coagulation Factor IV Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Human Coagulation Factor IV Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Human Coagulation Factor IV Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Human Coagulation Factor IV Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Human Coagulation Factor IV Market Share by Country (2021-2026) Table 164. Asia-Pacific Human Coagulation Factor IV Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Human Coagulation Factor IV Market Share Forecast by Country (2027-2032) Table 166. Latin America Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Human Coagulation Factor IV Sales by Country (2021-2026) & (k units) Table 168. Latin America Human Coagulation Factor IV Sales Market Share by Country (2021-2026) Table 169. Latin America Human Coagulation Factor IV Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Human Coagulation Factor IV Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Human Coagulation Factor IV Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Human Coagulation Factor IV Market Share by Country (2021-2026) Table 174. Latin America Human Coagulation Factor IV Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Human Coagulation Factor IV Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Human Coagulation Factor IV Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Human Coagulation Factor IV Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Human Coagulation Factor IV Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Human Coagulation Factor IV Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Human Coagulation Factor IV Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Human Coagulation Factor IV Market Share by Country (2021-2026) Table 184. Middle East and Africa Human Coagulation Factor IV Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Human Coagulation Factor IV Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Human Coagulation Factor IV Distributors List Table 189. Human Coagulation Factor IV Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Human Coagulation Factor IV Image Figure 2. Global Human Coagulation Factor IV Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor IV Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Coagulation Factor IV Sales (2021-2032) & (k units) Figure 5. Calcium Ion Image Figure 6. Global Calcium Ion Sales YoY Growth (2021-2032) & (k units) Figure 7. Calcium Compounds Image Figure 8. Global Calcium Compounds Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Human Coagulation Factor IV Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Coagulation Factor IV Market Share by Type 2025 VS 2032 Figure 11. North America Human Coagulation Factor IV Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Coagulation Factor IV Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Coagulation Factor IV Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Coagulation Factor IV Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Coagulation Factor IV Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Coagulation Factor IV Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Coagulation Factor IV Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Coagulation Factor IV Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Coagulation Factor IV Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Coagulation Factor IV Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Coagulation Factor IV Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Personal Clinic Image Figure 26. Global Personal Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Human Coagulation Factor IV Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Human Coagulation Factor IV Market Share by Application 2025 VS 2032 Figure 31. North America Human Coagulation Factor IV Sales Market Share in Volume by Application in 2025 Figure 32. North America Human Coagulation Factor IV Sales Market Share in Value by Application in 2025 Figure 33. Europe Human Coagulation Factor IV Sales Market Share in Volume by Application in 2025 Figure 34. Europe Human Coagulation Factor IV Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Human Coagulation Factor IV Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Human Coagulation Factor IV Sales Market Share in Value by Application in 2025 Figure 37. Latin America Human Coagulation Factor IV Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Human Coagulation Factor IV Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Human Coagulation Factor IV Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Human Coagulation Factor IV Sales Market Share in Value by Application in 2025 Figure 41. North America Human Coagulation Factor IV Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Human Coagulation Factor IV Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Human Coagulation Factor IV Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Human Coagulation Factor IV Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Coagulation Factor IV Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Human Coagulation Factor IV Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Coagulation Factor IV Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Human Coagulation Factor IV Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Coagulation Factor IV Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Human Coagulation Factor IV Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Coagulation Factor IV Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Human Coagulation Factor IV Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Coagulation Factor IV Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Human Coagulation Factor IV Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Coagulation Factor IV Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Human Coagulation Factor IV Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Coagulation Factor IV Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Human Coagulation Factor IV Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Coagulation Factor IV Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Human Coagulation Factor IV Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Human Coagulation Factor IV Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Human Coagulation Factor IV Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Calcium Ion
  • Calcium Compounds
Applications
  • Hospital
  • Personal Clinic
  • Others
Companies covered
  • BPL
  • CSL
  • Greencross
  • Grifols
  • Kedrion
  • Octapharma
  • Baxter
  • Bayer
  • Biogen
  • Hualan Bio
  • Pfizer
  • RAAS
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Coagulation Factor IV Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Coagulation Factor IV Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Coagulation Factor IV Market by Type
  6. 1.3.1 Calcium Ion
  7. 1.3.2 Calcium Compounds
  8. 1.4 Global Human Coagulation Factor IV Market Size by Type
  9. 1.4.1 Global Human Coagulation Factor IV Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Coagulation Factor IV Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Coagulation Factor IV Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Coagulation Factor IV Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Coagulation Factor IV Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Coagulation Factor IV Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Coagulation Factor IV Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Coagulation Factor IV Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Coagulation Factor IV Industry Trends
  2. 2.2 Human Coagulation Factor IV Industry Drivers
  3. 2.3 Human Coagulation Factor IV Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor IV Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Coagulation Factor IV Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Coagulation Factor IV Sales (2021-2026)
  3. 3.3 Global Top Players by Human Coagulation Factor IV Price (2021-2026)
  4. 3.4 Global Human Coagulation Factor IV Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Coagulation Factor IV Major Company Production Sites & Headquarters
  6. 3.6 Global Human Coagulation Factor IV Company, Product Type & Application
  7. 3.7 Global Human Coagulation Factor IV Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Coagulation Factor IV Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Coagulation Factor IV Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Coagulation Factor IV Tier 1, Tier 2, and Tier 3
4 Human Coagulation Factor IV Regional Status and Outlook
  1. 4.1 Global Human Coagulation Factor IV Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Coagulation Factor IV Historic Market Size by Region
  3. 4.2.1 Global Human Coagulation Factor IV Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Coagulation Factor IV Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Coagulation Factor IV Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Coagulation Factor IV Forecasted Market Size by Region
  7. 4.3.1 Global Human Coagulation Factor IV Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Coagulation Factor IV Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Coagulation Factor IV Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Coagulation Factor IV by Application
  1. 5.1 Human Coagulation Factor IV Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Personal Clinic
  4. 5.1.3 Others
  5. 5.2 Global Human Coagulation Factor IV Market Size by Application
  6. 5.2.1 Global Human Coagulation Factor IV Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Coagulation Factor IV Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Coagulation Factor IV Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Coagulation Factor IV Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Coagulation Factor IV Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Coagulation Factor IV Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Coagulation Factor IV Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Coagulation Factor IV Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BPL
  2. 6.1.1 BPL Company Information
  3. 6.1.2 BPL Business Overview
  4. 6.1.3 BPL Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BPL Human Coagulation Factor IV Product Portfolio
  6. 6.1.5 BPL Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Human Coagulation Factor IV Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Greencross
  14. 6.3.1 Greencross Company Information
  15. 6.3.2 Greencross Business Overview
  16. 6.3.3 Greencross Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Greencross Human Coagulation Factor IV Product Portfolio
  18. 6.3.5 Greencross Recent Developments
  19. 6.4 Grifols
  20. 6.4.1 Grifols Company Information
  21. 6.4.2 Grifols Business Overview
  22. 6.4.3 Grifols Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Grifols Human Coagulation Factor IV Product Portfolio
  24. 6.4.5 Grifols Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Human Coagulation Factor IV Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 Octapharma
  32. 6.6.1 Octapharma Company Information
  33. 6.6.2 Octapharma Business Overview
  34. 6.6.3 Octapharma Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Octapharma Human Coagulation Factor IV Product Portfolio
  36. 6.6.5 Octapharma Recent Developments
  37. 6.7 Baxter
  38. 6.7.1 Baxter Company Information
  39. 6.7.2 Baxter Business Overview
  40. 6.7.3 Baxter Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Baxter Human Coagulation Factor IV Product Portfolio
  42. 6.7.5 Baxter Recent Developments
  43. 6.8 Bayer
  44. 6.8.1 Bayer Company Information
  45. 6.8.2 Bayer Business Overview
  46. 6.8.3 Bayer Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer Human Coagulation Factor IV Product Portfolio
  48. 6.8.5 Bayer Recent Developments
  49. 6.9 Biogen
  50. 6.9.1 Biogen Company Information
  51. 6.9.2 Biogen Business Overview
  52. 6.9.3 Biogen Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Biogen Human Coagulation Factor IV Product Portfolio
  54. 6.9.5 Biogen Recent Developments
  55. 6.10 Hualan Bio
  56. 6.10.1 Hualan Bio Company Information
  57. 6.10.2 Hualan Bio Business Overview
  58. 6.10.3 Hualan Bio Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hualan Bio Human Coagulation Factor IV Product Portfolio
  60. 6.10.5 Hualan Bio Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Human Coagulation Factor IV Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 RAAS
  68. 6.12.1 RAAS Company Information
  69. 6.12.2 RAAS Business Overview
  70. 6.12.3 RAAS Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 RAAS Human Coagulation Factor IV Product Portfolio
  72. 6.12.5 RAAS Recent Developments
  73. 6.13 Novo Nordisk
  74. 6.13.1 Novo Nordisk Company Information
  75. 6.13.2 Novo Nordisk Business Overview
  76. 6.13.3 Novo Nordisk Human Coagulation Factor IV Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Novo Nordisk Human Coagulation Factor IV Product Portfolio
  78. 6.13.5 Novo Nordisk Recent Developments
7 North America by Country
  1. 7.1 North America Human Coagulation Factor IV Sales by Country
  2. 7.1.1 North America Human Coagulation Factor IV Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Coagulation Factor IV Sales by Country (2021-2026)
  4. 7.1.3 North America Human Coagulation Factor IV Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Coagulation Factor IV Market Size by Country
  6. 7.2.1 North America Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Coagulation Factor IV Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Coagulation Factor IV Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Coagulation Factor IV Sales by Country
  2. 8.1.1 Europe Human Coagulation Factor IV Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Coagulation Factor IV Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Coagulation Factor IV Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Coagulation Factor IV Market Size by Country
  6. 8.2.1 Europe Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Coagulation Factor IV Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Coagulation Factor IV Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Coagulation Factor IV Sales by Country
  2. 9.1.1 Asia-Pacific Human Coagulation Factor IV Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Coagulation Factor IV Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Coagulation Factor IV Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Coagulation Factor IV Market Size by Country
  6. 9.2.1 Asia-Pacific Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Coagulation Factor IV Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Coagulation Factor IV Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Coagulation Factor IV Sales by Country
  2. 10.1.1 South America Human Coagulation Factor IV Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Coagulation Factor IV Sales by Country (2021-2026)
  4. 10.1.3 South America Human Coagulation Factor IV Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Coagulation Factor IV Market Size by Country
  6. 10.2.1 South America Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Coagulation Factor IV Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Coagulation Factor IV Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Coagulation Factor IV Sales by Country
  2. 11.1.1 Middle East and Africa Human Coagulation Factor IV Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Coagulation Factor IV Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Coagulation Factor IV Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Coagulation Factor IV Market Size by Country
  6. 11.2.1 Middle East and Africa Human Coagulation Factor IV Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Coagulation Factor IV Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Coagulation Factor IV Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Coagulation Factor IV Value Chain Analysis
  2. 12.1.1 Human Coagulation Factor IV Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Coagulation Factor IV Production Mode & Process
  7. 12.2 Human Coagulation Factor IV Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Coagulation Factor IV Distributors
  10. 12.2.3 Human Coagulation Factor IV Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst